Chart of the Day: ADMA Biologics - Hitting New Highs
The Chart of the Day belongs to the biomedical company ADMA Biologics (ADMA) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals,...
Why Adma Biologics Stock Crushed the Market on Friday
The network of FDA-approved collection facilities continues to grow.
Why Adma Biologics Was Trouncing the Market Today
The company beat analyst estimates for both revenue and profitability, and raised revenue guidance.
Why Shares of ADMA Biologics Are Climbing Thursday
The company, which focuses on infectious diseases, reported its second-quarter earnings on Wednesday after the markets closed.
Adma Biologics (ADMA) Reports Q1 Loss, Tops Revenue Estimates
Adma Biologics (ADMA) delivered earnings and revenue surprises of 40% and 10.84%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?